New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 14  •  02:32PM ET
30.11
Dollar change
+0.31
Percentage change
1.03
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings35 Perf Week0.61%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM70.46M Perf Month8.77%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter22.04%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High30.42 -1.05% Perf Half Y31.17%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 60.31% Perf YTD28.71%
Active/Passive Quant Type Tagsmedical Flows% 1M0.57% Volatility0.46% 0.64% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M4.17% ATR (14)0.43 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.55% RSI (14)60.42 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.42 Perf 10Y-
Expense0.54% Growth/Value SMA201.90% Flows% 3Y Rel Volume0.28 Prev Close29.80
Inverse/Leveraged Market Cap SMA507.06% Flows% 5Y Avg Volume3.04K Price30.11
IPOOct 31, 2024 Option/ShortNo / Yes SMA20020.89% Trades Volume683 Change1.03%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.